Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT2012072310340N1Phase 3Completed
Phase 3 trial of propofol, sponsored by Golestan University of Medical Sciences. Primary endpoint: Pain severity induced by propofol injection. Started Mar 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT2012072310340N1.